Osteopore Limited (ASX:OSX)

Market Cap	4.76M +16.4%
Revenue (ttm)	2.85M +5.5%
Net Income	-3.36M
EPS	-0.03
Shares Out	432.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,369,858
Average Volume	25,136,699
Open	0.0100
Previous Close	0.0100
Day's Range	0.0100 - 0.0100
52-Week Range	0.0060 - 0.0480
Beta	-0.05
RSI	48.41
Earnings Date	Feb 27, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical impl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2024, Osteopore's revenue was 2.76 million, an increase of 24.60% compared to the previous year's 2.22 million. Losses were -3.35 million, -31.19% less than in 2023.